{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:41:05Z","timestamp":1790257265604,"version":"4.1.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0133509","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T18:06:42Z","timestamp":1438279602000},"page":"e0133509","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein"],"prefix":"10.1371","volume":"10","author":[{"given":"Valentine U.","family":"Chukwuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Hicar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J.","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Joyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyros A.","family":"Kalams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Landucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald N.","family":"Forthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Spearman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm.1949","article-title":"Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?","volume":"15","author":"L Stamatatos","year":"2009","journal-title":"Nat Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1128\/JVI.01708-08","article-title":"Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia","volume":"82","author":"GD Tomaras","year":"2008","journal-title":"J Virol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"11651","DOI":"10.1128\/JVI.01762-08","article-title":"Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C","volume":"82","author":"JM Binley","year":"2008","journal-title":"J Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.2984774","article-title":"Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients","volume":"228","author":"WG Robey","year":"1985","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00002030-199106000-00001","article-title":"Assembly and morphology of HIV: potential effect of structure on viral function","volume":"5","author":"HR Gelderblom","year":"1991","journal-title":"AIDS"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.1998.9398","article-title":"HIV-1 gag proteins: diverse functions in the virus life cycle","volume":"251","author":"EO Freed","year":"1998","journal-title":"Virology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1128\/JVI.68.5.3232-3242.1994","article-title":"Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly","volume":"68","author":"P Spearman","year":"1994","journal-title":"J Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0092-8674(89)90873-8","article-title":"Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells","volume":"59","author":"D Gheysen","year":"1989","journal-title":"Cell"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/rmv.449","article-title":"Virus-like particles as HIV-1 vaccines","volume":"15","author":"LX Doan","year":"2005","journal-title":"Rev Med Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e28314","DOI":"10.1371\/journal.pone.0028314","article-title":"Efficient production of HIV-1 virus-like particles from a mammalian expression vector requires the N-terminal capsid domain","volume":"6","author":"P Jalaguier","year":"2011","journal-title":"PloS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00002030-199803000-00001","article-title":"HIV p17 enhances lymphocyte proliferation and HIV-1 replication after binding to a human serum factor","volume":"12","author":"MA De Francesco","year":"1998","journal-title":"AIDS"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"9972","DOI":"10.1073\/pnas.142274699","article-title":"HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor","volume":"99","author":"MA De Francesco","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","first-page":"13","article-title":"The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells","volume":"33","author":"S Li","year":"2010","journal-title":"New Microbiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1096-9071(199703)51:3<145::AID-JMV2>3.0.CO;2-6","article-title":"Comparison of antibody responses to different forms of HIV-1 core antigens by epitope mapping","volume":"51","author":"C Truong","year":"1997","journal-title":"J Med Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/JVI.71.4.2799-2809.1997","article-title":"Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1","volume":"71","author":"JM Binley","year":"1997","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/JVI.63.1.267-272.1989","article-title":"Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping","volume":"63","author":"LD Papsidero","year":"1989","journal-title":"J Virol"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1128\/JVI.65.9.4798-4804.1991","article-title":"Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells","volume":"65","author":"F Shang","year":"1991","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2249.1995.tb05529.x","article-title":"The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression","volume":"99","author":"D Chargelegue","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1099\/0022-1317-69-8-2109","article-title":"Monoclonal antibodies directed against human immunodeficiency virus (HIV) gag proteins with specificity for conserved epitopes in HIV-1, HIV-2 and simian immunodeficiency virus","volume":"69","author":"M Niedrig","year":"1988","journal-title":"J Gen Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00002030-198912000-00008","article-title":"Epitope location of 13 anti-gag HIV-1 monoclonal antibodies using oligopeptides and their cross reactivity with HIV-2","volume":"3","author":"RB Ferns","year":"1989","journal-title":"AIDS"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1126\/science.1186430","article-title":"Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus","volume":"328","author":"R Xu","year":"2010","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/QAI.0b013e3181dc98a3","article-title":"Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV","volume":"54","author":"MD Hicar","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1128\/JVI.66.9.5667-5670.1992","article-title":"The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle","volume":"66","author":"X Yu","year":"1992","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1128\/JVI.71.9.6582-6592.1997","article-title":"Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism","volume":"71","author":"P Spearman","year":"1997","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e84185","DOI":"10.1371\/journal.pone.0084185","article-title":"B cell responses to HIV antigen are a potent correlate of viremia in HIV-1 infection and improve with PD-1 blockade","volume":"8","author":"KJ Nicholas","year":"2013","journal-title":"PloS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1128\/JVI.75.15.6953-6961.2001","article-title":"Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells","volume":"75","author":"DN Forthal","year":"2001","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e1002234","DOI":"10.1371\/journal.ppat.1002234","article-title":"Maturation-induced cloaking of neutralization epitopes on HIV-1 particles","volume":"7","author":"AS Joyner","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/hyb.1998.17.73","article-title":"Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell","volume":"17","author":"A Ota","year":"1998","journal-title":"Hybridoma"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2133.2009.09576.x","article-title":"Primary cutaneous B-cell lymphoma is associated with somatically hypermutated immunoglobulin variable genes and frequent use of VH1-69 and VH4-59 segments","volume":"162","author":"M Perez","year":"2010","journal-title":"Br J Dermatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.4049\/jimmunol.174.6.3454","article-title":"VH1-46 is the dominant immunoglobulin heavy chain gene segment in rotavirus-specific memory B cells expressing the intestinal homing receptor alpha4beta7","volume":"174","author":"JH Weitkamp","year":"2005","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e1004103","DOI":"10.1371\/journal.ppat.1004103","article-title":"Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses","volume":"10","author":"Y Avnir","year":"2014","journal-title":"PLoS Pathog"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1073\/pnas.0308527100","article-title":"Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120","volume":"101","author":"CC Huang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"H","key":"ref34","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V97.4.1023","article-title":"1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen","volume":"97","author":"CH Chan","year":"2001","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molimm.2008.09.005","article-title":"Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1","volume":"46","author":"MK Gorny","year":"2009","journal-title":"Mol Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.coi.2013.09.010","article-title":"Impact of new sequencing technologies on studies of the human B cell repertoire","volume":"25","author":"JA Finn","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"ref37","first-page":"195","article-title":"Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers&apos; plasma against HIV-1 protein p17","volume":"40","author":"S Kageyama","year":"1996","journal-title":"Acta Virol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0133509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T18:07:52Z","timestamp":1599415672000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0133509"}},"subtitle":[],"editor":[{"given":"Nicholas J","family":"Mantis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0133509","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]}}}